Determinación de una mutación en el gen BRCA1 en una familia que presenta cáncer de mama hereditario

Background: Breast cancer is the main cause of death among women between 40 and 55 years old, in whom the hereditary cases are common. Therefore, the molecular diagnosis of germ line mutations involved in breast cancer susceptibility is relevant. BRCA1 and BRCA2 have been described as the two major...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gallardo C,Marcela, Faúndez J,Paola, Cruz,Adolfo, Rodríguez,Mario, Alvarez Z,Manuel, Carvallo SQ,Pilar
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2004
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000200010
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872004000200010
record_format dspace
spelling oai:scielo:S0034-988720040002000102005-11-23Determinación de una mutación en el gen BRCA1 en una familia que presenta cáncer de mama hereditarioGallardo C,MarcelaFaúndez J,PaolaCruz,AdolfoRodríguez,MarioAlvarez Z,ManuelCarvallo SQ,Pilar BRCA1 protein Breast neoplasms Genes, BRCA1 Background: Breast cancer is the main cause of death among women between 40 and 55 years old, in whom the hereditary cases are common. Therefore, the molecular diagnosis of germ line mutations involved in breast cancer susceptibility is relevant. BRCA1 and BRCA2 have been described as the two major genes involved in familial breast/ovarian cancer. We are performing a screening of BRCA1 and BRCA2 genes, in a group of 50 high risk Chilean families for breast/ovarian cancer. We have detected a mutation, 3936 C>T, that leads to a truncated protein, in two affected women from one of the families in study. Aim: To report the results of the screening for 3936 C>T in healthy relatives of index women. Material and me-thods: The molecular diagnosis of this mutation was offered to the healthy members of this family, and 17 relatives accepted to be tested. The region of the BRCA1 gene that includes the 3936 C>T mutation, was analyzed through PCR amplification, digestion with restriction enzyme BstNI, and direct sequencing. Results: 3936 C>T DNA mutation was present in 8 relatives. Conclusions: Considering the high risk of having a mutation in the BRCA1 gene, specially in pre-menopausal women, the molecualr diagnosis, genetic and clinical counseling are highly relevant. In Chile the molecualr diagnosis is still not widely applied (Rev Méd Chile 2004; 132: 203-8)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.132 n.2 20042004-02-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000200010es10.4067/S0034-98872004000200010
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic BRCA1 protein
Breast neoplasms
Genes, BRCA1
spellingShingle BRCA1 protein
Breast neoplasms
Genes, BRCA1
Gallardo C,Marcela
Faúndez J,Paola
Cruz,Adolfo
Rodríguez,Mario
Alvarez Z,Manuel
Carvallo SQ,Pilar
Determinación de una mutación en el gen BRCA1 en una familia que presenta cáncer de mama hereditario
description Background: Breast cancer is the main cause of death among women between 40 and 55 years old, in whom the hereditary cases are common. Therefore, the molecular diagnosis of germ line mutations involved in breast cancer susceptibility is relevant. BRCA1 and BRCA2 have been described as the two major genes involved in familial breast/ovarian cancer. We are performing a screening of BRCA1 and BRCA2 genes, in a group of 50 high risk Chilean families for breast/ovarian cancer. We have detected a mutation, 3936 C>T, that leads to a truncated protein, in two affected women from one of the families in study. Aim: To report the results of the screening for 3936 C>T in healthy relatives of index women. Material and me-thods: The molecular diagnosis of this mutation was offered to the healthy members of this family, and 17 relatives accepted to be tested. The region of the BRCA1 gene that includes the 3936 C>T mutation, was analyzed through PCR amplification, digestion with restriction enzyme BstNI, and direct sequencing. Results: 3936 C>T DNA mutation was present in 8 relatives. Conclusions: Considering the high risk of having a mutation in the BRCA1 gene, specially in pre-menopausal women, the molecualr diagnosis, genetic and clinical counseling are highly relevant. In Chile the molecualr diagnosis is still not widely applied (Rev Méd Chile 2004; 132: 203-8)
author Gallardo C,Marcela
Faúndez J,Paola
Cruz,Adolfo
Rodríguez,Mario
Alvarez Z,Manuel
Carvallo SQ,Pilar
author_facet Gallardo C,Marcela
Faúndez J,Paola
Cruz,Adolfo
Rodríguez,Mario
Alvarez Z,Manuel
Carvallo SQ,Pilar
author_sort Gallardo C,Marcela
title Determinación de una mutación en el gen BRCA1 en una familia que presenta cáncer de mama hereditario
title_short Determinación de una mutación en el gen BRCA1 en una familia que presenta cáncer de mama hereditario
title_full Determinación de una mutación en el gen BRCA1 en una familia que presenta cáncer de mama hereditario
title_fullStr Determinación de una mutación en el gen BRCA1 en una familia que presenta cáncer de mama hereditario
title_full_unstemmed Determinación de una mutación en el gen BRCA1 en una familia que presenta cáncer de mama hereditario
title_sort determinación de una mutación en el gen brca1 en una familia que presenta cáncer de mama hereditario
publisher Sociedad Médica de Santiago
publishDate 2004
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000200010
work_keys_str_mv AT gallardocmarcela determinaciondeunamutacionenelgenbrca1enunafamiliaquepresentacancerdemamahereditario
AT faundezjpaola determinaciondeunamutacionenelgenbrca1enunafamiliaquepresentacancerdemamahereditario
AT cruzadolfo determinaciondeunamutacionenelgenbrca1enunafamiliaquepresentacancerdemamahereditario
AT rodriguezmario determinaciondeunamutacionenelgenbrca1enunafamiliaquepresentacancerdemamahereditario
AT alvarezzmanuel determinaciondeunamutacionenelgenbrca1enunafamiliaquepresentacancerdemamahereditario
AT carvallosqpilar determinaciondeunamutacionenelgenbrca1enunafamiliaquepresentacancerdemamahereditario
_version_ 1718436136269905920